Skip to main content
. 2016 Feb;7(1):129–142. doi: 10.3978/j.issn.2078-6891.2015.131

Table 4. Outcomes after repeat CRS/HIPEC for colorectal primaries.

Author (citation) Study type Year N PCI Median overall survival (months) Median follow-up (months) Morbidity (grade 3 and 4) Mortality CC 0-1
Portilla et al. (31) R 1999 18 >12 (44.4%) 20.0 71.0 25.0% 0.0% 77.8%
Glehen et al. (32) R 2004 506 NA 57.6 (2nd) 53.0 22.9% 4.0% 74.5%
Kianmanesh et al. (33) R 2007 43 Gilly III-IV 77% 38.4 NA 39.0% (all grades) 2.3% 70.0%
Bijelic et al. (34) R 2007 49 15 (mean) 30.0 29.5 NA NA 69.2%
Goéré et al. (35) R 2015 139 11 (mean) 3-year survival 52.0% 60.0 23.0% intra-abdominal; 44.6% extra-abdominal 6.0% 100.0%
Williams et al. (36) Review 2014 18 5 (median) 22.6 (2nd) NA 16.7% 0.0% 88.9%
Braam et al. (37) R 2014 32 NA 43.0 26.6 22.0% 3.1% NA

CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; R, retrospective; N, number of patients; PCI, peritoneal cancer index; CC, completeness of cytoreduction; NA, not available.